Nanoform

Nanoform company information, Employees & Contact Information

Explore related pages

Related company profiles:

Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform’s platform technologies. The company focuses on reducing clinical attrition and on enhancing drug molecules’ performance through its nanoforming technologies and formulation services. Nanoform’s capabilities include GMP manufacturing, and its services span the small to large molecule development space with a focus on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications.

Company Details

Employees
159
Founded
-
Address
Viikinkaari 4, Helsinki,southern Finland 00790,finland
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Helsinki, Southern Finland
Looking for a particular Nanoform employee's phone or email?

Nanoform Questions

News

Will Nanoform Finland Oyj (4YL) stock beat value stocks - 2025 Short Interest & Risk Controlled Stock Pick Alerts - Trung tâm Dự báo KTTV quốc gia

Will Nanoform Finland Oyj (4YL) stock beat value stocks - 2025 Short Interest & Risk Controlled Stock Pick Alerts Trung tâm Dự báo KTTV quốc gia

Results of Nanoform Collaborative Study to be Presented at the 2025 Partnership Opportunities in Drug Delivery (PODD) Summit - TradingView

Results of Nanoform Collaborative Study to be Presented at the 2025 Partnership Opportunities in Drug Delivery (PODD) Summit TradingView

Nanoform Hydroxyapatite in Bone-regenerative Medicine & Associated Adverse Effects - ScienceDirect.com

Nanoform Hydroxyapatite in Bone-regenerative Medicine & Associated Adverse Effects ScienceDirect.com

Nanoform receives €5m loan from Finnish government to accelerate its nanotechnology - Pharmafile

Nanoform receives €5m loan from Finnish government to accelerate its nanotechnology Pharmafile

Nanoform - Disclosure of Major Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act - TradingView

Nanoform - Disclosure of Major Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act TradingView

(PDF) Chitosan and its Nanoform Regulates Physiological Processes and Antioxidant Mechanisms to Improve Drought Stress Tolerance of Vicia faba Plant - researchgate.net

(PDF) Chitosan and its Nanoform Regulates Physiological Processes and Antioxidant Mechanisms to Improve Drought Stress Tolerance of Vicia faba Plant researchgate.net

3 European Penny Stocks With Market Caps Over €20M To Watch - simplywall.st

3 European Penny Stocks With Market Caps Over €20M To Watch simplywall.st

Nanoform announces biological nanoparticle-forming technology - BioTechniques

Nanoform announces biological nanoparticle-forming technology BioTechniques

ABOUT NANOFORM - Life Science Leader

ABOUT NANOFORM Life Science Leader

AstraZeneca granted licence for Nanoform’s AI technology - PharmaTimes

AstraZeneca granted licence for Nanoform’s AI technology PharmaTimes

Natural approach of using nisin and its nanoform as food bio-preservatives against methicillin resistant Staphylococcus aureus and E.coli O157:H7 in yoghurt - BMC Veterinary Research

Natural approach of using nisin and its nanoform as food bio-preservatives against methicillin resistant Staphylococcus aureus and E.coli O157:H7 in yoghurt BMC Veterinary Research

Is Nanoform Finland Oyj (4YL) stock a buy before earnings results - Portfolio Return Summary & Low Risk Investment Opportunities - newser.com

Is Nanoform Finland Oyj (4YL) stock a buy before earnings results - Portfolio Return Summary & Low Risk Investment Opportunities newser.com

Nanoform starts Pivotal Human Bioequivalence Studies of Nanoenzalutamide - TradingView

Nanoform starts Pivotal Human Bioequivalence Studies of Nanoenzalutamide TradingView

Nanoform Finland Oyj's (HEL:NANOFH) latest 14% decline adds to one-year losses, institutional investors may consider drastic measures - simplywall.st

Nanoform Finland Oyj's (HEL:NANOFH) latest 14% decline adds to one-year losses, institutional investors may consider drastic measures simplywall.st

Fluorescence imaging analysis of distribution of indocyanine green in molecular and nanoform in tumor model - ScienceDirect.com

Fluorescence imaging analysis of distribution of indocyanine green in molecular and nanoform in tumor model ScienceDirect.com

Nanoform signs GMP manufacturing program with TargTex following formulation success - BioTechniques

Nanoform signs GMP manufacturing program with TargTex following formulation success BioTechniques

Will Nanoform Finland Oyj (4YL) stock split increase liquidity - July 2025 Levels & Daily Profit Focused Stock Screening - Trung tâm Dự báo KTTV quốc gia

Will Nanoform Finland Oyj (4YL) stock split increase liquidity - July 2025 Levels & Daily Profit Focused Stock Screening Trung tâm Dự báo KTTV quốc gia

Will Nanoform Finland Oyj (4YL) stock outperform Dow Jones - Gap Up & Scalable Portfolio Growth Ideas - newser.com

Will Nanoform Finland Oyj (4YL) stock outperform Dow Jones - Gap Up & Scalable Portfolio Growth Ideas newser.com

Nanoform hydroxyapatite in bone-regenerative medicine & associated adverse effects - ScienceDirect.com

Nanoform hydroxyapatite in bone-regenerative medicine & associated adverse effects ScienceDirect.com

Will Nanoform Finland Oyj (4YL) stock outperform Dow Jones - July 2025 Pullbacks & Capital Protection Trading Alerts - newser.com

Will Nanoform Finland Oyj (4YL) stock outperform Dow Jones - July 2025 Pullbacks & Capital Protection Trading Alerts newser.com

Gates Foundation backs Nanoform's work to improve drug access - Fierce Pharma

Gates Foundation backs Nanoform's work to improve drug access Fierce Pharma

Is Nanoform Finland Oyj (4YL) stock a buy before earnings results - IPO Watch & Target Return Focused Picks - newser.com

Is Nanoform Finland Oyj (4YL) stock a buy before earnings results - IPO Watch & Target Return Focused Picks newser.com

Nanoform, Celanese partner to develop nanoparticle-enabled drug delivery - Drug Delivery Business

Nanoform, Celanese partner to develop nanoparticle-enabled drug delivery Drug Delivery Business

Nanoform completes share issue - Speciality Chemicals Magazine

Nanoform completes share issue Speciality Chemicals Magazine

Nanoform appoints new Director to oversee Project Management - Cleanroom Technology

Nanoform appoints new Director to oversee Project Management Cleanroom Technology

Inspiring a new era of patient-centric medicines - Chemistry World

Inspiring a new era of patient-centric medicines Chemistry World

Nanoform receives ISO/IEC 27001:2013 certification for its Information Security Management System - BioTechniques

Nanoform receives ISO/IEC 27001:2013 certification for its Information Security Management System BioTechniques

Will Nanoform Finland Oyj (4YL) stock outperform Dow Jones - Analyst Upgrade & Stock Market Timing Techniques - newser.com

Will Nanoform Finland Oyj (4YL) stock outperform Dow Jones - Analyst Upgrade & Stock Market Timing Techniques newser.com

Will Nanoform Finland Oyj (4YL) stock outperform Dow Jones - July 2025 Closing Moves & Smart Swing Trading Alerts - newser.com

Will Nanoform Finland Oyj (4YL) stock outperform Dow Jones - July 2025 Closing Moves & Smart Swing Trading Alerts newser.com

Will Nanoform Finland Oyj (4YL) stock outperform Dow Jones - Earnings Miss & Weekly Watchlist of Top Performers - newser.com

Will Nanoform Finland Oyj (4YL) stock outperform Dow Jones - Earnings Miss & Weekly Watchlist of Top Performers newser.com

Multidisciplinary science kick starts innovation - Chemistry World

Multidisciplinary science kick starts innovation Chemistry World

Controlled Expansion Of Supercritical Solutions (CESS®) Technology - Pharmaceutical Online

Controlled Expansion Of Supercritical Solutions (CESS®) Technology Pharmaceutical Online

Nanoform solidifies IPO plans - - Global Corporate Venturing

Nanoform solidifies IPO plans - Global Corporate Venturing

Will Nanoform Finland Oyj (4YL) stock outperform Dow Jones - Quarterly Trade Review & Safe Capital Investment Plans - newser.com

Will Nanoform Finland Oyj (4YL) stock outperform Dow Jones - Quarterly Trade Review & Safe Capital Investment Plans newser.com

Pharmaceutical Development - Pharmaceutical Online

Pharmaceutical Development Pharmaceutical Online

New hires at Nanoform, Leo Pharma and Calliditas - PMLiVE

New hires at Nanoform, Leo Pharma and Calliditas PMLiVE

Nanoform shrinks drug particles | Helsinki Innovation Services | University of Helsinki - Helsinki.fi

Nanoform shrinks drug particles | Helsinki Innovation Services | University of Helsinki Helsinki.fi

Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO - PMLiVE

Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO PMLiVE

SATURN NITRO – A Microchip PIC32MK development board with Arduino Nano form factor - CNX Software

SATURN NITRO – A Microchip PIC32MK development board with Arduino Nano form factor CNX Software

Precitech says diamond turning of carbide better than grinding, using Nanoform Xtc - recyclingwasteworld.co.uk

Precitech says diamond turning of carbide better than grinding, using Nanoform Xtc recyclingwasteworld.co.uk

Precitech Introduces The Nanoform X Ultra Precision Machining System - machinetoolsonline.com

Precitech Introduces The Nanoform X Ultra Precision Machining System machinetoolsonline.com

Top Nanoform Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant